Lung Tumors of Uncertain Histogenesis

  • Annikka Weissferdt
  • Cesar A. Moran
Chapter

Abstract

The cell of origin of several rare lung tumors is still a matter of debate. Although some progress has been made in the last few decades in identifying the possible histogenesis of these tumors, their exact origins remain uncertain. Clear cell sugar tumor of lung, granular cell tumor, inflammatory pseudotumor, and sclerosing hemangioma are a group of tumors that fall into this category. A summary of the most pertinent features of these tumors is provided in Table 10.1.

Keywords

Cholesterol Sugar Surfactant Lymphoma Adenocarcinoma 

References

  1. 1.
    Liebow AA, Castelman B. Benign “clear cell tumors” of the lung. Am J Pathol. 1963;43:13a–4 (abstract).Google Scholar
  2. 2.
    Liebow AA, Castleman B. Benign clear cell (“sugar”) tumors of the lung. Yale J Biol Med. 1971;43:213–22.PubMedGoogle Scholar
  3. 3.
    Becker NH, Soifer I. Benign clear cell tumor (“sugar tumor”) of the lung. Cancer. 1971;27:712–9.PubMedGoogle Scholar
  4. 4.
    Andrion A, Mazzucco G, Gugliotta P, Monga G. Benign clear cell (sugar) tumor of the lung. A light microscopic, histochemical, and ultrastructural study with a review of the literature. Cancer. 1985;56:2657–63.PubMedGoogle Scholar
  5. 5.
    Gaffey MJ, Mills SE, Zarbo RJ, Weiss LM, Gown AM. Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol. 1991;15:644–53.PubMedGoogle Scholar
  6. 6.
    Lantuejoul S, Isaac S, Pinel N, Negoescu A, Guibert B, Brambilla E. Clear cell tumor of the lung: an immunohistochemical and ultrastructural study supporting a pericytic differentiation. Mod Pathol. 1997;10:1001–8.PubMedGoogle Scholar
  7. 7.
    Bonetti F, Pea M, Martignoni G, Zamboni G. PEC and sugar. Am J Surg Pathol. 1992;16:307–8.PubMedGoogle Scholar
  8. 8.
    Flieder DB, Travis WD. Clear cell “sugar” tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol. 1997;21:1242–7.PubMedGoogle Scholar
  9. 9.
    Fukuda T, Machinami R, Joshita T, Nagashima K. Benign clear cell tumor of the lung in an 8-year-old girl. Arch Pathol Lab Med. 1986;110:664–6.PubMedGoogle Scholar
  10. 10.
    Vijayabhaskar R, Mehta SS, Deodhar KK, Pramesh CS, Mistry RC. PEComa of the lung. J Cancer Res Ther. 2010;6:109–11.PubMedGoogle Scholar
  11. 11.
    Santana AN, Nunes FS, Ho N, Takagaki TY. A rare cause of ­hemoptysis: benign sugar (clear) cell tumor of the lung. Eur J Cardiothorac Surg. 2004;25:652–4.PubMedGoogle Scholar
  12. 12.
    Gora-Gebka M, Liberek A, Bako W, Szumera M, Korzon M, Jaskiewicz K. The “sugar” clear cell tumor of the lung-clinical presentation and diagnostic difficulties of an unusual lung tumor in youth. J Pediatr Surg. 2006;41:e27–9.PubMedGoogle Scholar
  13. 13.
    Kavunkal AM, Pandiyan MS, Philip MA, Parimelazhagan KN, Manipadam MT, Cherian VK. Large clear cell tumor of the lung mimicking malignant behavior. Ann Thorac Surg. 2007;83:310–2.PubMedGoogle Scholar
  14. 14.
    Sale GE, Kulander BG. ‘Benign’ clear-cell tumor (sugar tumor) of the lung with hepatic metastases ten years after resection of pulmonary primary tumor. Arch Pathol Lab Med. 1988;112:1177–8.PubMedGoogle Scholar
  15. 15.
    Parfitt JR, Keith JL, Megyesi JF, Ang LC. Metastatic PEComa to the brain. Acta Neuropathol. 2006;112:349–51.PubMedGoogle Scholar
  16. 16.
    Ye T, Chen H, Hu H, Wang J, Shen L. Malignant clear cell sugar tumor of the lung: patient case report. J Clin Oncol. 2010;28:e626–8.PubMedGoogle Scholar
  17. 17.
    Gaffey MJ, Mills SE, Askin FB, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV. Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol. 1990;14:248–59.PubMedGoogle Scholar
  18. 18.
    Gal AA, Koss MN, Hochholzer L, Chejfec G. An immunohistochemical study of benign clear cell (‘sugar’) tumor of the lung. Arch Pathol Lab Med. 1991;115:1034–8.PubMedGoogle Scholar
  19. 19.
    Adachi Y, Horie Y, Kitamura Y, Nakamura H, Taniguchi Y, Miwa K, Fujioka S, Nishimura M, Hayashi K. CD1a expression in PEComas. Pathol Int. 2008;58:169–73.PubMedGoogle Scholar
  20. 20.
    Adachi Y, Kitamura Y, Nakamura H, Taniguchi Y, Miwa K, Horie Y, Hayashi K. Benign clear (sugar) cell tumor of the lung with CD1a expression. Pathol Int. 2006;56:453–6.PubMedGoogle Scholar
  21. 21.
    Sale GF, Kulander BG. Benign clear cell tumor of lung with necrosis. Cancer. 1976;37:2355–8.PubMedGoogle Scholar
  22. 22.
    Deavers M, Guinee D, Koss MN, Travis WD. Granular cell tumors of the lung. Clinicopathologic study of 20 cases. Am J Surg Pathol. 1995;19:627–35.PubMedGoogle Scholar
  23. 23.
    Abrikossoff AI. Über Myome, ausgehend von der quergestreiften willkürlichen Muskulatur. Virchows Arch f Path Anat. 1926;260:215–33.Google Scholar
  24. 24.
    Azzopardi JG. Histogenesis of the granular-cell myoblastoma. J Pathol Bacteriol. 1956;71:85–94.PubMedGoogle Scholar
  25. 25.
    Pearse AG. The histogenesis of granular-cell myoblastoma (? granular-cell perineural fibroblastoma). J Pathol Bacteriol. 1950;62:351–62.PubMedGoogle Scholar
  26. 26.
    Fisher ER, Wechsler H. Granular cell myoblastoma--a misnomer. Electron microscopic and histochemical evidence concerning its Schwann cell derivation and nature (granular cell schwannoma). Cancer. 1962;15:936–54.PubMedGoogle Scholar
  27. 27.
    Ordóñez NG. Granular cell tumor: a review and update. Adv Anat Pathol. 1999;6:186–203.PubMedGoogle Scholar
  28. 28.
    Kramer R. Myoblastoma of the bronchus. Ann Otol Rhinol Laryngol. 1939;48:1083–6.Google Scholar
  29. 29.
    Wilson RW, Kirejczyk W. Pathological and radiological correlation of endobronchial neoplasms: part I, benign tumors. Ann Diagn Pathol. 1997;1:31–46.PubMedGoogle Scholar
  30. 30.
    De Clercq D, Van der Straeten M, Roels H. Granular cell myoblastoma of the bronchus. Eur J Respir Dis. 1983;64:72–6.PubMedGoogle Scholar
  31. 31.
    Ostermiller WE, Comer TP, Barker WL. Endobronchial granular cell myoblastoma. A report of three cases and review of the literature. Ann Thorac Surg. 1970;9:143–8.PubMedGoogle Scholar
  32. 32.
    Lauro S, Trasatti L, Bria E, Gelibter A, Larosa G, Vecchione A. Malignant bronchial Abrikossoff’s tumor and small cell lung cancer: a case report and review. Anticancer Res. 2001;21:563–5.PubMedGoogle Scholar
  33. 33.
    Jiang M, Anderson T, Nwogu C, Tan D. Pulmonary malignant granular cell tumor. World J Surg Oncol. 2003;1:22.PubMedGoogle Scholar
  34. 34.
    Al-Ghamdi AM, Flint JD, Muller NL, Stewart KC. Hilar pulmonary granular cell tumor: a case report and review of the literature. Ann Diagn Pathol. 2000;4:245–51.PubMedGoogle Scholar
  35. 35.
    Cutlan RT, Eltorky M. Pulmonary granular cell tumor coexisting with bronchogenic carcinoma. Ann Diagn Pathol. 2001;5:74–9.PubMedGoogle Scholar
  36. 36.
    Gabriel Jr JB, Thomas L, Mendoza CB, Chauhan PM. Granular cell tumor of the bronchus coexisting with a bronchogenic ­adenocarcinoma: a case report. J Surg Oncol. 1983;24:103–6.PubMedGoogle Scholar
  37. 37.
    Khansur T, Balducci L, Tavassoli M. Identification of desmosomes in the granular cell tumor. Implications in histologic diagnosis and histogenesis. Am J Surg Pathol. 1985;9:898–904.PubMedGoogle Scholar
  38. 38.
    Robinson JM, Knoll R, Henry DA. Intrathoracic granular cell ­myoblastoma. South Med J. 1988;81:1453–7.PubMedGoogle Scholar
  39. 39.
    Vaos G, Zavras N, Priftis K, Pierrakos P. Bronchial granular cell tumor in a child: impact of diagnostic delay on the type of surgical resection. J Pediatr Surg. 2006;41:1326–8.PubMedGoogle Scholar
  40. 40.
    Oparah SS, Subramanian VA. Granular cell myoblastoma of the bronchus: report of 2 cases and review of the literature. Ann Thorac Surg. 1976;22:199–202.PubMedGoogle Scholar
  41. 41.
    Schulster PL, Khan FA, Azueta V. Asymptomatic pulmonary granular cell tumor presenting as a coin lesion. Chest. 1975;68:256–8.PubMedGoogle Scholar
  42. 42.
    Thomas de Montpréville V, Dulmet EM. Granular cell tumours of the lower respiratory tract. Histopathology. 1995;27:257–62.PubMedGoogle Scholar
  43. 43.
    Mazur MT, Shultz JJ, Myers JL. Granular cell tumor. Immunohistochemical analysis of 21 benign tumors and one ­malignant tumor. Arch Pathol Lab Med. 1990;114:692–6.PubMedGoogle Scholar
  44. 44.
    Fang HY, Wu CY, Huang HJ, Lin YM. Granular cell tumor of the lung. Lung. 2010;188:355–7.PubMedGoogle Scholar
  45. 45.
    Daniel TM, Smith RH, Faunce HF, Sylvest VM. Transbronchoscopic versus surgical resection of tracheobronchial granular cell myoblastomas. Suggested approach based on follow-up of all treated cases. J Thorac Cardiovasc Surg. 1980;80:898–903.PubMedGoogle Scholar
  46. 46.
    Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer. 1956;9:53–75.PubMedGoogle Scholar
  47. 47.
    Haas JE, Yunis EJ. Totten RS ultrastructure of a sclerosing hemangioma of the lung. Cancer. 1972;30:512–8.PubMedGoogle Scholar
  48. 48.
    Katzenstein AL, Weise DL, Fulling K, Battifora H. So-called sclerosing hemangioma of the lung. Evidence for mesothelial origin. Am J Surg Pathol. 1983;7:3–14.PubMedGoogle Scholar
  49. 49.
    Huszar M, Suster S, Herczeg E, Geiger B. Sclerosing hemangioma of the lung. Immunohistochemical demonstration of mesenchymal origin using antibodies to tissue-specific intermediate filaments. Cancer. 1986;58:2422–7.PubMedGoogle Scholar
  50. 50.
    Hill GS, Eggleston JC. Electron microscopic study of so-called “pulmonary sclerosing hemangioma”. Report of a case suggesting epithelial origin. Cancer. 1972;30:1092–106.PubMedGoogle Scholar
  51. 51.
    Kennedy A. “Sclerosing haemangioma” of the lung: an alternative view of its development. J Clin Pathol. 1973;26:792–9.PubMedGoogle Scholar
  52. 52.
    Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer. 1985;55:116–23.PubMedGoogle Scholar
  53. 53.
    Yousem SA, Wick MR, Singh G, Katyal SL, Manivel JC, Mills SE, Legier J. So-called sclerosing hemangiomas of lung. An immunohistochemical study supporting a respiratory epithelial origin. Am J Surg Pathol. 1988;12:582–90.PubMedGoogle Scholar
  54. 54.
    Satoh Y, Tsuchiya E, Weng SY, Kitagawa T, Matsubara T, Nakagawa K, Kinoshita I, Sugano H. Pulmonary sclerosing hemangioma of the lung. A type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer. 1989;64:1310–7.PubMedGoogle Scholar
  55. 55.
    Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000;24:1531–6.PubMedGoogle Scholar
  56. 56.
    Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24:906–16.PubMedGoogle Scholar
  57. 57.
    Yamazaki K. Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and ­immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant ­proteins. Virchows Arch. 2004;445:45–53.PubMedGoogle Scholar
  58. 58.
    Tanaka I, Inoue M, Matsui Y, Oritsu S, Akiyama O, Takemura T, Fujiwara M, Kodama T, Shimosato Y. A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol. 1986;16:77–86.PubMedGoogle Scholar
  59. 59.
    Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y, Esumi H. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol. 1998;152:1065–9.PubMedGoogle Scholar
  60. 60.
    Sartori G, Bettelli S, Schirosi L, Bigiani N, Maiorana A, Cavazza A. Rossi GMicrosatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung. Am J Surg Pathol. 2007;31:1512–20.PubMedGoogle Scholar
  61. 61.
    Wang E, Lin D, Wang Y, Wu G, Yuan X. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol. 2004;35:503–8.PubMedGoogle Scholar
  62. 62.
    Spencer H, Nambu S. Sclerosing haemangiomas of the lung. Histopathology. 1986;10:477–87.PubMedGoogle Scholar
  63. 63.
    Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV. Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med. 2003;127:321–5.PubMedGoogle Scholar
  64. 64.
    Katzenstein AL, Gmelich JT, Carrington CB. Sclerosing ­hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol. 1980;4:343–56.PubMedGoogle Scholar
  65. 65.
    Maeda R, Isowa N, Miura H, Tokuyasu H, Kawasaki Y, Yamamoto K. Bilateral multiple sclerosing hemangiomas of the lung. Gen Thorac Cardiovasc Surg. 2009;57:667–70.PubMedGoogle Scholar
  66. 66.
    Lee ST, Lee YC, Hsu CY, Lin CC. Bilateral multiple sclerosing hemangiomas of the lung. Chest. 1992;101:572–3.PubMedGoogle Scholar
  67. 67.
    Hanaoka J, Ohuchi M, Inoue S, Sawai S, Tezuka N, Fujino S. Bilateral multiple pulmonary sclerosing hemangioma. Jpn J Thorac Cardiovasc Surg. 2005;53:157–61.PubMedGoogle Scholar
  68. 68.
    Soumil VJ, Navin B, Sangeeta D, Na J, Sharma S, Deshpande R. Multiple sclerosing hemangiomas of the lung. Asian Cardiovasc Thorac Ann. 2004;12:357–9.PubMedGoogle Scholar
  69. 69.
    de Koning DB, Drenth JP, Oyen WJ, Wagenaar M, Aliredjo RP, Nagengast FM. Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: report of a case. Dis Colon Rectum. 2007;50:1987–91.PubMedGoogle Scholar
  70. 70.
    Hosaka N, Sasaki T, Adachi K, Sato T, Tanaka T, Miura Y, Sawai T, Toki J, Hisha H, Okamura A, Takasu K, Ikehara S. Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis. Hum Pathol. 2004;35:764–8.PubMedGoogle Scholar
  71. 71.
    Devouassoux-Shisheboran M, de la Fouchardière A, Thivolet-Béjui F, Sourisseau-Millan ML, Guerin JC, Travis WD. Endobronchial variant of sclerosing hemangioma of the lung: histological and cytological features on endobronchial material. Mod Pathol. 2004;17:252–7.PubMedGoogle Scholar
  72. 72.
    Wani Y, Notohara K, Tsukayama C, Okumura N. Sclerosing hemangioma with florid endobronchial and endobronchiolar growth. Virchows Arch. 2007;450:221–3.PubMedGoogle Scholar
  73. 73.
    Kim KH, Sul HJ, Kang DY. Sclerosing hemangioma with lymph node metastasis. Yonsei Med J. 2003;44:150–4.PubMedGoogle Scholar
  74. 74.
    Khoury JD, Shephard MN, Moran CA. Cystic sclerosing haemangioma of the lung. Histopathology. 2003;43:239–43.PubMedGoogle Scholar
  75. 75.
    Moran CA, Zeren H, Koss MN. Sclerosing hemangioma of the lung. Granulomatous variant. Arch Pathol Lab Med. 1994;118:1028–30.PubMedGoogle Scholar
  76. 76.
    Dacic S, Sasatomi E, Swalsky PA, Kim DW, Finkelstein SD, Yousem SA. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar ­molecular pathogenesis. Arch Pathol Lab Med. 2004;128:880–4.PubMedGoogle Scholar
  77. 77.
    Pareja MJ, Vargas MT, Sánchez A, Ibáñez J, González-Cámpora R. Cytogenetic study of a pulmonary sclerosing hemangioma. Cancer Genet Cytogenet. 2009;195:80–4.PubMedGoogle Scholar
  78. 78.
    Yano M, Yamakawa Y, Kiriyama M, Hara M, Murase T. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg. 2002;73:981–3.PubMedGoogle Scholar
  79. 79.
    Komatsu T, Fukuse T, Wada H, Sakurai T. Pulmonary sclerosing hemangioma with pulmonary metastasis. Thorac Cardiovasc Surg. 2006;54:348–9.PubMedGoogle Scholar
  80. 80.
    Wei S, Tian J, Song X, Chen Y. Recurrence of pulmonary sclerosing hemangioma. Thorac Cardiovasc Surg. 2008;56:120–2.PubMedGoogle Scholar
  81. 81.
    Childress WG, Adie GC. Plasma cell tumors of the mediastinum and lung; report of 2 cases. J Thorac Surg. 1950;19:794–9.PubMedGoogle Scholar
  82. 82.
    Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer. 1973;31:191–208.PubMedGoogle Scholar
  83. 83.
    Bates T, Hull OH. Histiocytoma of the bronchus; report of case in a six-year old child. AMA J Dis Child. 1958;95:53–6.PubMedGoogle Scholar
  84. 84.
    Dubilier LD, Bryant LR, Danielson GK. Histiocytoma (fibrous xanthoma) of the lung. Am J Surg. 1968;115:420–6.PubMedGoogle Scholar
  85. 85.
    Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol. 1990;94:538–46.PubMedGoogle Scholar
  86. 86.
    Tchertkoff V, Lee BY, Wagner BM. Plasma cell granuloma of lung; case report and review of literature. Dis Chest. 1963;44:440–3.PubMedGoogle Scholar
  87. 87.
    Alvarez-Fernandez E, Escalona-Zapata J. Pulmonary plasma cell granuloma – an electron microscopic and tissue culture study. Histopathology. 1983;7:279–86.PubMedGoogle Scholar
  88. 88.
    Berardi RS, Lee SS, Chen HP, Stines GJ. Inflammatory pseudotumors of the lung. Surg Gynecol Obstet. 1983;156:89–96.PubMedGoogle Scholar
  89. 89.
    Monzon CM, Gilchrist GS, Burgert Jr EO, O’Connell EJ, Telander RL, Hoffman AD, Li CY. Plasma cell granuloma of the lung in children. Pediatrics. 1982;70:268–74.PubMedGoogle Scholar
  90. 90.
    Biselli R, Ferlini C, Fattorossi A, Boldrini R, Bosman C. Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases. Cancer. 1996;77:778–84.PubMedGoogle Scholar
  91. 91.
    Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol. 1998;11:364–8.PubMedGoogle Scholar
  92. 92.
    Janik JS, Janik JP, Lovell MA, Hendrickson RJ, Bensard DD, Greffe BS. Recurrent inflammatory pseudotumors in children. J Pediatr Surg. 2003;38:1491–5.PubMedGoogle Scholar
  93. 93.
    Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and ­immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509–20.PubMedGoogle Scholar
  94. 94.
    Hartman GE, Shochat SJ. Primary pulmonary neoplasms of childhood: a review. Ann Thorac Surg. 1983;36:108–19.PubMedGoogle Scholar
  95. 95.
    Agrons GA, Rosado-de-Christenson ML, Kirejczyk WM, Conran RM, Stocker JT. Pulmonary inflammatory pseudotumor: ­radiologic features. Radiology. 1998;206:511–8.PubMedGoogle Scholar
  96. 96.
    Alexiou C, Obuszko Z, Beggs D, Morgan WE. Inflammatory pseudotumors of the lung. Ann Thorac Surg. 1998;66:948–50.PubMedGoogle Scholar
  97. 97.
    Ishida T, Oka T, Nishino T, Tateishi M, Mitsudomi T, Sugimachi K. Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg. 1989;48:90–5.PubMedGoogle Scholar
  98. 98.
    Kim TS, Han J, Kim GY, Lee KS, Kim H, Kim J. Pulmonary inflammatory pseudotumor (inflammatory myofibroblastic tumor): CT features with pathologic correlation. J Comput Assist Tomogr. 2005;29:633–9.PubMedGoogle Scholar
  99. 99.
    Vujanić GM, Dojĉinov D. Inflammatory pseudotumor of the lung in children. Pediatr Hematol Oncol. 1991;8:121–9.PubMedGoogle Scholar
  100. 100.
    Wick MR, Ritter JH, Nappi O. Inflammatory sarcomatoid carcinoma of the lung: report of three cases and clinicopathologic comparison with inflammatory pseudotumors in adult patients. Hum Pathol. 1995;26:1014–21.PubMedGoogle Scholar
  101. 101.
    Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal ­rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569–76.PubMedGoogle Scholar
  102. 102.
    Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest. 2003;83:1255–65.PubMedGoogle Scholar
  103. 103.
    Kinoshita Y, Tajiri T, Ieiri S, Nagata K, Taguchi T, Suita S, Yamazaki K, Yoshino I, Maehara Y, Kohashi K, Yamamoto H, Oda Y, Tsuneyoshi M. A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusion. Pediatr Surg Int. 2007;23:595–9.PubMedGoogle Scholar
  104. 104.
    Gómez-Román JJ, Sánchez-Velasco P, Ocejo-Vinyals G, Hernández-Nieto E, Leyva-Cobián F, Val-Bernal JF. Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). Am J Surg Pathol. 2001;25:624–9.PubMedGoogle Scholar
  105. 105.
    Farris 3rd AB, Kradin RL. Follicular localization of dendritic cells in a xanthomatous inflammatory tumor of lung associated with human herpes virus-8 infection. Virchows Arch. 2006;449:726–9.PubMedGoogle Scholar
  106. 106.
    Yamamoto H, Yamaguchi H, Aishima S, Oda Y, Kohashi K, Oshiro Y, Tsuneyoshi M. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am J Surg Pathol. 2009;33:1330–40.PubMedGoogle Scholar
  107. 107.
    Takeuchi K, Soda M, Togashi Y, Sugawara E, Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H, Ishikawa Y. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clin Cancer Res. 2011;17:3341–8.PubMedGoogle Scholar
  108. 108.
    Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2002;34:354–62.PubMedGoogle Scholar
  109. 109.
    Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiao S, Yi ES, Fletcher CD, Fletcher JA. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157:377–84.PubMedGoogle Scholar
  110. 110.
    Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159:411–5.PubMedGoogle Scholar
  111. 111.
    Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2003;37:98–105.PubMedGoogle Scholar
  112. 112.
    Panagopoulos I, Nilsson T, Domanski HA, Isaksson M, Lindblom P, Mertens F, Mandahl N. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer. 2006;118:1181–6.PubMedGoogle Scholar
  113. 113.
    Tavora F, Shilo K, Ozbudak IH, Przybocki JM, Wang G, Travis WD, Franks TJ. Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases. Mod Pathol. 2007;20:995–9.PubMedGoogle Scholar
  114. 114.
    Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Fujimura M, Nakanuma Y. IgG4-Positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710–7.PubMedGoogle Scholar
  115. 115.
    Malhotra V, Tatke M, Malik R, Gondal R, Beohar PC, Kumar S, Puri V. An unusual case of plasma cell granuloma involving lung and brain. Indian J Cancer. 1991;28:223–7.PubMedGoogle Scholar
  116. 116.
    Petridis AK, Hempelmann RG, Hugo HH, Eichmann T, Mehdorn HM. Metastatic low-grade inflammatory myofibroblastic tumor (IMT) in the central nervous system of a 29-year-old male patient. Clin Neuropathol. 2004;23:158–66.PubMedGoogle Scholar
  117. 117.
    Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, Pairolero PC. Inflammatory pseudotumors of the lung. Ann Thorac Surg. 1999;67:933–6.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Annikka Weissferdt
    • 1
  • Cesar A. Moran
    • 1
  1. 1.Department of PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations